| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $62.5M | +25.3% |
| SG&A Expense | $12.2M | +10.8% |
| Operating Income | -$76.2M | -14.1% |
| Interest Expense | $3.4M | — |
| Net Income | -$77.5M | -16.8% |
| EPS (Basic) | -$0.75 | +1.3% |
| EPS (Diluted) | -$0.75 | +1.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $75.7M | -31.0% |
| Current Assets | $78.9M | -29.4% |
| Total Assets | $92.4M | -26.2% |
| Current Liabilities | $15.1M | +39.7% |
| Total Liabilities | $46.1M | +261.4% |
| Stockholders' Equity | $46.3M | -58.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$65.1M | -21.2% |
| Capital Expenditures | $2.7M | -31.9% |
| Investing Cash Flow | -$3.0M | +45.0% |
| Financing Cash Flow | $34.1M | -51.9% |
| Free Cash Flow | -$67.8M | -17.6% |